Literature DB >> 35851376

Viral variant-resolved wastewater surveillance of SARS-CoV-2 at national scale.

Fabian Amman1,2, Rudolf Markt3, Lukas Endler1,2, Sebastian Hupfauf3, Benedikt Agerer1, Anna Schedl1,2, Lukas Richter4, Melanie Zechmeister5, Martin Bicher5,6, Georg Heiler7,8, Petr Triska1,2, Matthew Thornton1,2, Thomas Penz1, Martin Senekowitsch1, Jan Laine1, Zsofia Keszei1, Peter Klimek7,9, Fabiana Nägele3, Markus Mayr3, Beatrice Daleiden10, Martin Steinlechner10, Harald Niederstätter10, Petra Heidinger11, Wolfgang Rauch12, Christoph Scheffknecht13, Gunther Vogl14, Günther Weichlinger15, Andreas Otto Wagner3, Katarzyna Slipko16, Amandine Masseron16, Elena Radu16,17, Franz Allerberger4, Niki Popper5,6, Christoph Bock1,18, Daniela Schmid4, Herbert Oberacher10, Norbert Kreuzinger16, Heribert Insam3, Andreas Bergthaler19,20.   

Abstract

SARS-CoV-2 surveillance by wastewater-based epidemiology is poised to provide a complementary approach to sequencing individual cases. However, robust quantification of variants and de novo detection of emerging variants remains challenging for existing strategies. We deep sequenced 3,413 wastewater samples representing 94 municipal catchments, covering >59% of the population of Austria, from December 2020 to February 2022. Our system of variant quantification in sewage pipeline designed for robustness (termed VaQuERo) enabled us to deduce the spatiotemporal abundance of predefined variants from complex wastewater samples. These results were validated against epidemiological records of >311,000 individual cases. Furthermore, we describe elevated viral genetic diversity during the Delta variant period, provide a framework to predict emerging variants and measure the reproductive advantage of variants of concern by calculating variant-specific reproduction numbers from wastewater. Together, this study demonstrates the power of national-scale WBE to support public health and promises particular value for countries without extensive individual monitoring.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 35851376     DOI: 10.1038/s41587-022-01387-y

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   68.164


  65 in total

1.  Socioeconomic impacts of COVID-19 in low-income countries.

Authors:  Anna Josephson; Talip Kilic; Jeffrey D Michler
Journal:  Nat Hum Behav       Date:  2021-03-30

2.  Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity.

Authors:  Carolina Lucas; Chantal B F Vogels; Inci Yildirim; Jessica E Rothman; Peiwen Lu; Valter Monteiro; Jeff R Gehlhausen; Melissa Campbell; Julio Silva; Alexandra Tabachnikova; Mario A Peña-Hernandez; M Catherine Muenker; Mallery I Breban; Joseph R Fauver; Subhasis Mohanty; Jiefang Huang; Albert C Shaw; Albert I Ko; Saad B Omer; Nathan D Grubaugh; Akiko Iwasaki
Journal:  Nature       Date:  2021-10-11       Impact factor: 69.504

3.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

Review 4.  Tracking virus outbreaks in the twenty-first century.

Authors:  Nathan D Grubaugh; Jason T Ladner; Philippe Lemey; Oliver G Pybus; Andrew Rambaut; Edward C Holmes; Kristian G Andersen
Journal:  Nat Microbiol       Date:  2018-12-13       Impact factor: 17.745

Review 5.  Towards a genomics-informed, real-time, global pathogen surveillance system.

Authors:  Jennifer L Gardy; Nicholas J Loman
Journal:  Nat Rev Genet       Date:  2017-11-13       Impact factor: 53.242

6.  Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series.

Authors:  Thao T Truong; Alex Ryutov; Utsav Pandey; Rebecca Yee; Lior Goldberg; Deepa Bhojwani; Paibel Aguayo-Hiraldo; Benjamin A Pinsky; Andrew Pekosz; Lishuang Shen; Scott D Boyd; Oliver F Wirz; Katharina Röltgen; Moiz Bootwalla; Dennis T Maglinte; Dejerianne Ostrow; David Ruble; Jennifer H Han; Jaclyn A Biegel; Maggie Li; ChunHong Huang; Malaya K Sahoo; Pia S Pannaraj; Maurice O'Gorman; Alexander R Judkins; Xiaowu Gai; Jennifer Dien Bard
Journal:  EBioMedicine       Date:  2021-04-26       Impact factor: 8.143

Review 7.  The variant gambit: COVID-19's next move.

Authors:  Jessica A Plante; Brooke M Mitchell; Kenneth S Plante; Kari Debbink; Scott C Weaver; Vineet D Menachery
Journal:  Cell Host Microbe       Date:  2021-03-01       Impact factor: 31.316

Review 8.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

Review 9.  The socio-economic implications of the coronavirus pandemic (COVID-19): A review.

Authors:  Maria Nicola; Zaid Alsafi; Catrin Sohrabi; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Maliha Agha; Riaz Agha
Journal:  Int J Surg       Date:  2020-04-17       Impact factor: 6.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.